🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is evaluate the response, safety and tolerability...
Status
Terminated
Location
Duke University Medical Center
Start Date
2012-02
Trial ID
NCT00978432
Treatments Being Tested
The purpose of this study is to assess the safety and ability of panobinost...
Status
Completed
Location
Department of Infectious Diseases, Aarhus University Hospital
Start Date
2012-09
Trial ID
NCT01680094
Treatments Being Tested
This study will evaluate the efficacy and safety of LBH589B in adult patien...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2007-02-19
Trial ID
NCT00451035
Treatments Being Tested
Aim of this prospective randomized trial is to compare maintenance treatmen...
Status
Terminated
Location
Robert Bosch Krankenhaus
Start Date
2018-07-24
Trial ID
NCT04326764
Treatments Being Tested
The purpose of the study is to examine both efficacy of LBH589 in treating ...
Status
Completed
Location
Queen Elizabeth II Health Sciences Centre
Start Date
2010-11
Trial ID
NCT01238692
The long-term objective of this research is to understand the molecular mec...
Status
Withdrawn
Location
Tulane Cancer Center, Comprehensive Clinic, CTRC
Start Date
2009-09
Trial ID
NCT00993642
Treatments Being Tested
This study is looking at the effects of Panobinostat, an investigational tr...
Status
Completed
Location
Peter MacCallum Cancer Centre
Start Date
2012-07-16
Trial ID
NCT01658241
Treatments Being Tested
Panobinostat (LBH589) is a deacetylase inhibitor (DACi) which belongs to a ...
Status
Completed
Location
University of Utah / Huntsman Cancer Institute
Start Date
2010-03
Trial ID
NCT00997399
Treatments Being Tested
The purpose of the study is to assess the benefit of oral panobinostat mono...
Status
Completed
Location
UCLA
Start Date
2009-02
Trial ID
NCT00777049
Treatments Being Tested
This study is a prospective, open-label, randomized, three-arm, dose-escala...
Status
Completed
Location
Massachusetts General Hospital CRS (MGH CRS)
Start Date
2016-05
Trial ID
NCT02471430
Treatments Being Tested